Health Care & Life Sciences » Biotechnology | Jiangxi Boya Bio-Pharmaceutical Co. Ltd.

Jiangxi Boya Bio-Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
409
346
718
472
502
1,193
Total Accounts Receivable
87
97
135
246
596
925
Inventories
116
128
214
289
518
604
Other Current Assets
6
32
6
3
139
324
Total Current Assets
618
603
1,074
1,011
1,754
3,047
Net Property, Plant & Equipment
191
213
453
617
777
873
Total Investments and Advances
36
37
34
84
149
144
Intangible Assets
159
160
603
610
821
899
Other Assets
-
3
21
94
153
94
Total Assets
1,004
1,018
2,188
2,419
3,670
5,073
ST Debt & Current Portion LT Debt
2
1
24
2
98
Accounts Payable
13
12
106
86
158
Income Tax Payable
9
9
11
38
45
Other Current Liabilities
127
65
102
124
415
Total Current Liabilities
150
87
244
250
716
Long-Term Debt
-
-
22
22
450
Deferred Taxes
-
4
6
6
7
Total Liabilities
154
90
275
280
1,174
Common Equity (Total)
792
858
1,875
2,093
2,426
Total Shareholders' Equity
792
858
1,875
2,093
2,426
Total Equity
847
924
1,908
2,132
2,484
Liabilities & Shareholders' Equity
1,004
1,018
2,188
2,419
3,670
Accumulated Minority Interest
55
66
33
39
59
Non-Equity Reserves
4
4
5
7
11

About Jiangxi Boya Bio-Pharmaceutical Co.

View Profile
Address
333 Huiquan Road
Fuzhou Jiangxi 344000
China
Employees -
Website http://www.china-boya.com
Updated 07/08/2019
Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. It operates through the following business segments: Blood Products, Diabetes Medication, and Biochemical drugs. The Blood Products segment includes products such as albumin, immunoglobulin, and blood clotting factors.